Related Experiment Videos
Aspirin and stroke prevention: how much?
1College of Osteopathic Medicine of the Pacific, Pomona, Calif.
Summary
Aspirin at 1300 mg daily is recommended for stroke prevention after transient ischemic attack (TIA). This dosage is effective as a sole antiplatelet agent, clarifying existing confusion regarding optimal use.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Media focus on aspirin for heart attack prevention overshadows its role in stroke prevention.
- Clinical data on aspirin for stroke prevention post-transient ischemic attack (TIA) exists but lacks clarity on optimal dosing and comparative effectiveness.
- Confusion persists regarding appropriate antiplatelet agent selection and dosage for TIA patients.
Purpose of the Study:
- To review the mechanism of action of aspirin in stroke prevention.
- To provide clinical trial evidence supporting aspirin's efficacy for stroke prevention following TIA.
- To recommend a specific daily dosage of aspirin as the primary oral antiplatelet therapy.
Main Methods:
- Literature review of clinical trials and pharmacological data.
- Analysis of aspirin's mechanism of action.
- Evaluation of evidence for stroke prevention in TIA patients.
Main Results:
- Aspirin's antiplatelet mechanism is detailed.
- Clinical trials provide a rationale for specific dosing strategies.
- Evidence supports aspirin's role in preventing recurrent stroke after TIA.
Conclusions:
- A daily dose of 1300 mg of aspirin is recommended for stroke prevention in patients with TIA.
- This dosage is proposed as the sole orally administered antiplatelet agent.
- The review aims to resolve confusion surrounding aspirin's use in stroke prevention.